- About
- Programs
- News and Events
- eRequest
Upcoming Events
-
Online Controlled Substances Summit
Virtual Meeting
Public Session: July 25, 2024 | 11am-3pm (eastern)
Real-World Evidence Webinar Series:
Natural History Studies and Registries in the Development of Rare Disease Treatments
Public Workshop: In-Person and Virtual
Each year, the Reagan-Udall Foundation for the FDA conducts an annual public meeting to discuss its activities in support of the U.S. Food and Drug Administration.
Past Events
Qualifying Biomarkers to Support Rare Disease Regulatory Pathways
-
Advancing Psychedelic Clinical Study DesignVirtual Public Meeting
Day 1: January 31, 2024 | 10am-2pm (eastern)
Front-of-Package Nutrition LabelingVirtual Public Meeting
Integrating Clinical Studies Into Health Care Delivery:
Post-Market Evidence Generation for Medical ProductsVirtual Public Meeting
Strategies for Improving Public Understanding of FDA-Regulated Products
Virtual Public Meeting
Mitigating Risks from Human Xylazine Exposure
Public Meeting: In-person and Virtual
-
On September 12 and 13, the Foundation, in collaboration with the U.S. Food and Drug Administration, hosted a webinar to explore Good Clinical Practice Considerations for Trials with Pragmatic or Decentralized Features.
RAISE: Lessons Learned & Practical Applications for the Future
June 15, 2023
2-4 pm ET
RAISE: Reactions to Barriers, Facilitators, and Proposed Solutions
Thursday, June 1, 2023
2-3 PM ET